College Station, TX – May 18, 2025
In a landmark philanthropic move, Texas A\&M University has announced a $30 million donation dedicated to advancing research, treatment, and care for individuals living with Parkinson’s disease, spina bifida, and autism. This substantial commitment is aimed at fostering innovation in neurological and developmental health and enhancing patient support systems across Texas and beyond.
The donation, made possible through a combination of university funds and private contributions from alumni and benefactors, will be distributed across several research initiatives, clinical programs, and community outreach services. The funds will be administered through Texas A\&M’s Health Science Center and in partnership with affiliated medical institutions.
“We believe in using our resources and expertise to drive meaningful change,” said Texas A\&M President Mark A. Welsh III. “This gift represents our university’s dedication to addressing some of the most pressing medical challenges affecting families across our nation. By supporting research, education, and patient care, we hope to improve outcomes and provide hope to those impacted by these conditions.”
Breakdown of the $30 Million Allocation of the total donation:
$12 million will go toward Parkinson’s disease research, including studies on early detection, advanced treatment options, and support systems for patients and caregivers.
$10 million will be allocated for autism spectrum disorder programs, supporting both clinical and behavioral research, early intervention programs, and family education services.
$8 million will fund initiatives related to spina bifida, such as prenatal diagnostics, surgical treatments, and physical therapy support for children and adults living with the condition.
In addition to bolstering research, part of the donation will help expand Texas A\&M’s clinical facilities to provide comprehensive care services. Plans are already underway to establish a new Neurodevelopmental and Neurological Disorders Center at the College of Medicine, expected to open in 2026.
A Lifeline for Families and Patients
For patients and families affected by these chronic and often debilitating conditions, Texas A\&M’s donation offers not only hope but also tangible support. According to the CDC, more than 500,000 Americans live with Parkinson’s disease, over 100,000 have spina bifida, and approximately 1 in 36 children are diagnosed with autism each year.
“This investment is truly transformative,” said Dr. Sarah Olivarez, Director of Pediatric Neurology at Texas A\&M Health. “With this funding, we can accelerate breakthroughs in care and reach underserved communities that often struggle with access to specialists and long-term therapy.”
Community and National Impact
Beyond the university’s academic environment, the donation aims to serve as a catalyst for broader collaboration with national health agencies and nonprofits. Texas A\&M will also launch scholarship programs to train future medical professionals in neurodevelopmental and neurological specialties, addressing the growing need for skilled practitioners in these fields.
Alumni and advocacy groups have applauded the announcement, calling it a testament to Texas A\&M’s core values of leadership, service, and excellence.
“This is about more than just medicine—it’s about community,” said Aggie alum and donor, Rebecca Langston. “Our university has the heart and the capacity to make a lasting difference, and this is just the beginning.”
As the news ripples across academic, medical, and advocacy circles, Texas A\&M’s \$30 million gift is already being hailed as a pivotal moment in the fight against Parkinson’s, spina bifida, and autism—proof that bold action from institutions can change lives.
